EFPIA Newsletter 16 February 2023

News     10 February 2023 EFPIA reaction to leak of the proposed pharmaceutical legislation Whether it is naivety, blind optimism or a more conscious decision for Europe to rely on innovation from the US and... Read more →         09 February 2023 Industry Statement on the earthquakes in Turkey and Syria Industry will continue to work with partners and authorities across Europe to provide further support where possible.... Read more →

Blogs     15 February 2023 Pushing the boundaries of science to beat childhood cancers Earlier diagnosis, more new treatments and better data can help beat paediatric cancers Read more →

AMR: New incentives – a call for action

There are around 400,000 AMR related deaths in the EU every year, and the figure is rising. Inaction isn't an option: common infections could become untreatable, and routine treatments like tooth extractions but also chemotherapy and caesareans – too risky to carry out. The time is now, we need a meaningful EU pull incentive to drive the development of a sustainable R&D pipeline for novel antimicrobials.

Events     28 FEB 2023   Let’s make a joint health check for CVD and diabetes happen European Parliament Join us in the European Parliament from 28 February - 2 March for a week of insights, events and perspectives from people... Learn more →       28 FEB 2023   3rd International conference on Rare Diseases: Greek chapter Technopolis City of Athens Under the theme “Leveraging the momentum for a comprehensive rare disease strategy”, the 3rd International Conference... Learn more →

	16 MAR 2023			GetReal Institute Annual Conference 2023 Utrecht, Netherlands A European Outlook on Real World Evidence in a Global Context Learn more →

	22 MAR 2023			DIA Europe 2023 - 35th Anniversary of the event Basel, Switzerland 35th Anniversary of the event Learn more →

EHDEN Academy Courses for Non-Experts Extended to 4th Module on Patient Reported Outcomes With module 4 now posted, EHDEN (European Health Data & Evidence Network), and IMI H20 (Health Outcomes Observatory) launched their lay-language course collaboration on Patient Reported Outcomes. This is the 4th course in the series of introductory-level courses on the EHDEN Academy, which have been co-produced in partnership with the European Patients’ Forum. You can access the course, plus many other free training materials at the EHDEN Academy, here.

What we are reading EU Data Protection Reductions Would ‘Irretrievably Sabotage’ Pharma Industry 15 February 2023  (Pink Sheet) Read more → Global Trends in R&D 2023 15 February 2023  (IQVIA) Read more → European Colorectal Cancer Awareness Month 15 February 2023  (Digestive Cancers) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe